Actively Recruiting
Safety and Feasibility Study of ColoSeal Intraluminal Colonic Diversion System in Adults Undergoing Rectal and Rectosigmoid Cancer Surgery
Led by Averto Medical, Inc. · Updated on 2026-10-13
90
Participants Needed
3
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and feasibility of the ColoSeal Intraluminal Colonic Diversion ICD System in adult patients with rectal and rectosigmoid cancer undergoing colorectal resection with an anastomosis. This device is designed to protect a damaged colon segment, such as a surgical anastomosis, leak, or perforation, from fecal contact for up to 14 days. The study consists of two prospective, multicenter, single-arm studies following identical protocols. Participants will have scheduled surgical resections using the surgeons preferred technique, including open, laparoscopic, or robotic approaches. After completing the colon anastomosis and confirming no leak, the ICD Device is inserted transanally and positioned with a delivery system. The devices anchor is placed in healthy bowel above the damaged area, then fixed externally to the skin with sutures and a collection bag attached. The device stays in place for about 10 days, followed by leak testing before removal. During the study, participants will undergo assessments including leak tests at insertion and removal, monitoring for device-related adverse events up to 90 days after the procedure, and evaluations of procedure success, device migration, anastomotic leakage, ostomy need, and successful device removal. Follow-up includes monitoring for complications and outcomes for up to three months post-procedure, ensuring participant safety and device feasibility.
CONDITIONS
Brief Title
ColoSeal™ ICD System Safety and Feasibility Studies
Research Team
G
Grace Carlson, MD
K
Kenton Fong, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here